Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Molnupiravir bulk supplier for pharma manufacturers

Molnupiravir 200 mg Suppliers & Bulk Manufacturers

Available Forms: Oral capsule

Available Strengths: 200 mg

Reference Brands: Lagevrio®(Us & EU)

Category: Anti Covid Medicines

Molnupiravir, an oral antiviral for mild to moderate COVID-19, is approved in countries like India, UK, and Japan, under brands such as Lagevrio (Merck) and Molnatris (Dr. Reddy’s). Though not FDA-approved for general use in the US, it's widely distributed across Asia, LATAM, and MENA. PharmaB2B platforms connect global buyers with certified Molnupiravir suppliers, ensuring bulk availability, fast shipping, and regulatory compliance.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Molnupiravir and Tocilizumab are high-demand COVID-19 treatments sourced globally through trusted PharmaB2B platforms. Molnupiravir (200 mg capsules, branded as Lagevrio, Molnatris, Molnunat) is used for mild to moderate cases, while Tocilizumab (IV and SC, branded as Actemra, Tocira) treats severe inflammation in hospitalized patients. Approved in the US, EU, and Asia, these products are available in bulk from verified manufacturers and exporters. PharmaB2B networks offer global distribution, regulatory-compliant sourcing, and competitive pricing. Connect with reliable suppliers today to ensure seamless supply chain solutions for hospitals, tenders, and distributors worldwide.

Molnupiravir — third party manufacturing & bulk supply

Molnupiravir 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Molnupiravir is supplied as Oral capsule — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Molnupiravir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Molnupiravir →
Back to Listing

Frequently Asked Questions

Molnupiravir is listed as Oral capsule in 200 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Molnupiravir is referenced against Lagevrio®(Us & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Favipiravir Tablet

Strength:
200 mg, 400 mg, 600 mg

Form: Tablet

Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)

View Details
Tocilizumab

Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)

Form: IV injection, SQ Injection

Reference Brands: Actemra®(US); RoActemra®(EU)

View Details
Remdesivir

Strength:
Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)

Form: Lyophilized powder for IV & Injection

Reference Brands: Veklury® (EU & US)

View Details
Nirmatrelvir / Ritonavir Tablet

Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)

Form: Tablet

Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)

View Details
Baricitinib

Strength:
2 mg, 4 mg

Form: Tablet

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.